Complexes of Fe3+ engage
in rich aqueous solution speciation
chemistry in which discrete molecules can react with solvent water
to form multinuclear μ-oxo and μ-hydroxide bridged species.
Here we demonstrate how pH- and concentration-dependent equilibration
between monomeric and μ-oxo-bridged dimeric Fe3+ complexes
can be controlled through judicious ligand design. We purposed this
chemistry to develop a first-in-class Fe3+-based MR imaging
probe, Fe-PyCy2AI, that undergoes relaxivity change via pH-mediated
control of monomer vs dimer speciation. The monomeric complex exists
in a S = 5/2 configuration capable of inducing efficient T
1-relaxation, whereas the antiferromagnetically
coupled dimeric complex is a much weaker relaxation agent. The mechanisms
underpinning the pH dependence on relaxivity were interrogated by
using a combination of pH potentiometry, 1H and 17O relaxometry, electronic absorption spectroscopy, bulk magnetic
susceptibility, electron paramagnetic resonance spectroscopy, and
X-ray crystallography measurements. Taken together, the data demonstrate
that PyCy2AI forms a ternary complex with high-spin Fe3+ and a rapidly exchanging water coligand, [Fe(PyCy2AI)(H2O)]+ (ML), which can deprotonate to form
the high-spin complex [Fe(PyCy2AI)(OH)] (ML(OH)). Under
titration conditions of 7 mM Fe complex, water coligand deprotonation
occurs with an apparent pK
a 6.46. Complex ML(OH) dimerizes to form the antiferromagnetically coupled
dimeric complex [(Fe(PyCy2AI))2O] ((ML)
2
O) with an association constant
(K
a) of 5.3 ± 2.2 mM–1. The relaxivity of the monomeric complexes are between 7- and 18-fold
greater than the antiferromagnetically coupled dimer at applied field
strengths ranging between 1.4 and 11.7 T. ML(OH) and (ML)
2
O interconvert rapidly
within the pH 6.0–7.4 range that is relevant to human pathophysiology,
resulting in substantial observed relaxivity change. Controlling Fe3+ μ-oxo bridging interactions through rational ligand
design and in response to local chemical environment offers a robust
mechanism for biochemically responsive MR signal modulation.